{"log_id": 186212338788499001, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 0.000167, "average": 0.986413, "min": 0.973491}, "location": {"width": 52, "top": 324, "height": 29, "left": 541}, "words": "指标"}, {"probability": {"variance": 0.010374, "average": 0.929114, "min": 0.656859}, "location": {"width": 159, "top": 331, "height": 27, "left": 849}, "words": "850mgqd组(N"}, {"probability": {"variance": 0.007994, "average": 0.958306, "min": 0.710591}, "location": {"width": 175, "top": 328, "height": 31, "left": 1139}, "words": "安慰剂组(N-48"}, {"probability": {"variance": 0.007359, "average": 0.937098, "min": 0.751894}, "location": {"width": 121, "top": 376, "height": 29, "left": 397}, "words": " HR(95% CD"}, {"probability": {"variance": 0.008067, "average": 0.953271, "min": 0.610139}, "location": {"width": 210, "top": 383, "height": 25, "left": 977}, "words": "0.513(0.319,0.826)"}, {"probability": {"variance": 0.031865, "average": 0.913718, "min": 0.443123}, "location": {"width": 201, "top": 424, "height": 29, "left": 333}, "words": "客观缓解率〔CH"}, {"probability": {"variance": 0.001198, "average": 0.959739, "min": 0.915481}, "location": {"width": 38, "top": 434, "height": 22, "left": 986}, "words": "38%"}, {"probability": {"variance": 0.00093, "average": 0.973891, "min": 0.892459}, "location": {"width": 303, "top": 475, "height": 31, "left": 335}, "words": "临床获益率(CR+PR+SD)"}, {"probability": {"variance": 0.00444, "average": 0.95687, "min": 0.817159}, "location": {"width": 79, "top": 482, "height": 25, "left": 957}, "words": "51.06%"}, {"probability": {"variance": 0.014183, "average": 0.929613, "min": 0.526664}, "location": {"width": 1181, "top": 523, "height": 45, "left": 251}, "words": "注:FAS:全分析集;mOS;中位总生存期:mPFS中位无进展生存期;CR:完全缓解;PR:部分缓解"}, {"probability": {"variance": 0.001408, "average": 0.974326, "min": 0.901418}, "location": {"width": 159, "top": 575, "height": 31, "left": 253}, "words": "SD:疾病稳定"}, {"probability": {"variance": 0.004868, "average": 0.956057, "min": 0.801457}, "location": {"width": 162, "top": 616, "height": 34, "left": 258}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.999394, "min": 0.998952}, "location": {"width": 121, "top": 660, "height": 34, "left": 308}, "words": "药理作用"}, {"probability": {"variance": 0.004319, "average": 0.978542, "min": 0.60925}, "location": {"width": 1137, "top": 701, "height": 50, "left": 303}, "words": "作用机制:本品为一种小分子血管内皮细胞生长因子受体2( VFGFR-2)酪氨酸激酶抑制"}, {"probability": {"variance": 0.009111, "average": 0.956118, "min": 0.566462}, "location": {"width": 1107, "top": 749, "height": 41, "left": 249}, "words": "剂,可抑制肿瘤血管生成。动物研究表明本品可明显抑制多种小鼠肿瘤模型的肿瘤生长"}, {"probability": {"variance": 2.5e-05, "average": 0.992273, "min": 0.985925}, "location": {"width": 121, "top": 790, "height": 34, "left": 306}, "words": "毒理研究"}, {"probability": {"variance": 0.004662, "average": 0.981802, "min": 0.57912}, "location": {"width": 1137, "top": 833, "height": 47, "left": 303}, "words": "长期毒性t大鼠26周长期毒性研究(5,15,50mg/kg天)显示本品无毒性反应剂量为5"}, {"probability": {"variance": 0.010892, "average": 0.951231, "min": 0.545983}, "location": {"width": 1149, "top": 879, "height": 41, "left": 251}, "words": "mg/kg(雌鼠)和15mg/kg(雄鼠)。海性反应剂量为15mg/kg(雌鼠)和50mg/kg(雄鼠)"}, {"probability": {"variance": 0.001774, "average": 0.983572, "min": 0.811747}, "location": {"width": 1187, "top": 916, "height": 50, "left": 249}, "words": "毒性反应包括雌性大鼠白细胞升高及提前出现早期慢性进行性肾病样的形态学改变雌雄大鼠"}, {"probability": {"variance": 0.014513, "average": 0.961605, "min": 0.440948}, "location": {"width": 1192, "top": 959, "height": 47, "left": 246}, "words": "红系改变、切齿断裂、耗食量下降及肝肾功能的轻度改变,除切齿的改变未能完全恢复外,其"}, {"probability": {"variance": 0.010061, "average": 0.970037, "min": 0.36221}, "location": {"width": 1190, "top": 1002, "height": 52, "left": 246}, "words": "它改变在停药后基本恢复犬39周长期毒性研究(20,60,120mg/kg天)显示,仅20mgkg"}, {"probability": {"variance": 0.004973, "average": 0.980699, "min": 0.54464}, "location": {"width": 1165, "top": 1046, "height": 50, "left": 271}, "words": "条雄性犬精子生成障碍,其它均未见药物相关性的变化,恢复期也未见异常改变:剂量≤20"}, {"probability": {"variance": 0.000112, "average": 0.994712, "min": 0.963209}, "location": {"width": 230, "top": 1092, "height": 34, "left": 251}, "words": "mg/kg为安全剂量"}, {"probability": {"variance": 0.016321, "average": 0.948584, "min": 0.426421}, "location": {"width": 1128, "top": 1130, "height": 50, "left": 303}, "words": "遗传毒性:伤寒沙门氏菌回复突变试验、中国仓鼠肺成纤维细胞染色体畸变试验、小鼠"}, {"probability": {"variance": 0.000255, "average": 0.989079, "min": 0.94759}, "location": {"width": 443, "top": 1176, "height": 36, "left": 246}, "words": "骨髓微核试验显示本品无遗传毒性"}, {"probability": {"variance": 0.013209, "average": 0.953317, "min": 0.537291}, "location": {"width": 1130, "top": 1219, "height": 45, "left": 303}, "words": "生殖毒性:SD大鼠于妊娠第6-15天灌胃给予本品16mg/kg天,有一定程度的胚胎-胎仔"}, {"probability": {"variance": 0.012867, "average": 0.949754, "min": 0.494543}, "location": {"width": 1190, "top": 1261, "height": 45, "left": 244}, "words": "毒性,可使治鼠骨骼发育延迟并有畸效应,但无母体毒性。对胚胎任无毒性作用的剂量"}, {"probability": {"variance": 0.003092, "average": 0.974595, "min": 0.838544}, "location": {"width": 137, "top": 1306, "height": 34, "left": 249}, "words": "为4mg/kg"}, {"probability": {"variance": 5e-06, "average": 0.998558, "min": 0.99138}, "location": {"width": 326, "top": 1347, "height": 36, "left": 303}, "words": "本品尚未进行致癌性研究"}, {"probability": {"variance": 0, "average": 0.999188, "min": 0.998513}, "location": {"width": 194, "top": 1388, "height": 38, "left": 251}, "words": "【药代动力学】"}, {"probability": {"variance": 0.002893, "average": 0.972672, "min": 0.797817}, "location": {"width": 1133, "top": 1436, "height": 47, "left": 301}, "words": "本品在36例健康受试者和52例转移性实体瘤患者进行了不同剂童单次和多次给药的药代"}, {"probability": {"variance": 0, "average": 0.999332, "min": 0.998537}, "location": {"width": 157, "top": 1489, "height": 34, "left": 244}, "words": "动力学研究"}, {"probability": {"variance": 1e-05, "average": 0.996724, "min": 0.993499}, "location": {"width": 61, "top": 1539, "height": 29, "left": 301}, "words": "吸收"}, {"probability": {"variance": 0.005146, "average": 0.982371, "min": 0.511923}, "location": {"width": 1139, "top": 1587, "height": 41, "left": 292}, "words": "健康受试者单次空腹口服250mg,500mg和750mg后,在体内吸收较快,原形药血浆浓度"}, {"probability": {"variance": 0.012167, "average": 0.947123, "min": 0.390093}, "location": {"width": 1185, "top": 1633, "height": 50, "left": 246}, "words": "平均达峰时间约为1.7~2.3h;消除较慢,平均消除半衰期为7.9-94h在250mg和500mg剂"}, {"probability": {"variance": 0.003679, "average": 0.974326, "min": 0.641924}, "location": {"width": 1162, "top": 1681, "height": 47, "left": 242}, "words": "量组,原形药物血浆暴露量与剂量成正比例,750mg剂量组原形药的暴露量未见进一步增加"}, {"probability": {"variance": 0.000384, "average": 0.991323, "min": 0.912634}, "location": {"width": 635, "top": 1731, "height": 36, "left": 244}, "words": "未见明显性别差异。具体各药代动力学参数见表5"}, {"probability": {"variance": 0.005033, "average": 0.969288, "min": 0.679488}, "location": {"width": 959, "top": 1781, "height": 36, "left": 287}, "words": "表5.健康受试者单次空腹口服250mg、500mg和750mg阿帕尼片的药代动力学参数"}, {"probability": {"variance": 0, "average": 0.729971, "min": 0.729971}, "location": {"width": 77, "top": 1841, "height": 25, "left": 929}, "words": " AUCC"}, {"probability": {"variance": 1e-06, "average": 0.99719, "min": 0.996223}, "location": {"width": 54, "top": 1857, "height": 31, "left": 518}, "words": "剂量"}, {"probability": {"variance": 0.094626, "average": 0.782484, "min": 0.347453}, "location": {"width": 63, "top": 1866, "height": 29, "left": 1082}, "words": " u()"}, {"probability": {"variance": 0.047391, "average": 0.744906, "min": 0.46809}, "location": {"width": 91, "top": 1889, "height": 29, "left": 934}, "words": " ng hmd)"}, {"probability": {"variance": 0.00272, "average": 0.975623, "min": 0.724312}, "location": {"width": 655, "top": 1939, "height": 29, "left": 509}, "words": "250mg12656±3751.7±0.942222627.88±3.13"}], "language": 3}